Drug Type Monoclonal antibody |
Synonyms anti-CD160 antibody(MAT Biopharma), anti-CD160 mAbs(ElsaLys Biotech/MABLife) + [1] |
Target |
Mechanism CD160 inhibitors(CD160 molecule inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Solid tumor | Discovery | FR | 07 May 2020 |